Search

everythinglearnresearchcommunity

for

Search:↓

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Topical tofacitinib is effective and safe for treating alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Erdr1 could be a new marker for diagnosing hair loss.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Hair loss significantly affects quality of life, especially for women, in Pakistan.

A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

New alopecia treatments aim for better results and fewer side effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Steroids are the best treatment for Alopecia Areata with few side effects.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Dupilumab for skin problems might reactivate hair loss in some patients.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Immunotherapy can help treat severe alopecia areata.

JAK inhibitors show promise as a future treatment for hair loss.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.